Science logo

SAG - Science Share Price

314p -1.0  -0.3%

Last Trade - 7:49am

Sector
Industrials
Size
Small Cap
Market Cap £129.6m
Enterprise Value £123.7m
Revenue £70.5m
Position in Universe 947th / 1809
Bullish
Bearish
Unlock SAG Revenue
Momentum
Relative Strength (%)
1m -3.79%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -7.35%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
28.3 31.2 36.9 40.8 48.7 57.2 73.0 73.1 +15.1%
-27.9 +15.8 +5.4 -8.1 +6.5 -77.1 +721.2 +0.52
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Science GroupPLC revenues increased 56% to £36.9M. Net income decreased17% to £2M. Revenues reflect Service Operating Businesssegment increase of 25% to £28.8M, Freehold propertiessegment increase of 15% to £580K. Net income was offset byCorporate segment loss increase from £331K to £922K.Dividend per share totaled to £0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for SAG
Graphical History

Revenue

SAG Revenue Unlock SAG Revenue

Net Income

SAG Net Income Unlock SAG Revenue

Normalised EPS

SAG Normalised EPS Unlock SAG Revenue

PE Ratio Range

SAG PE Ratio Range Unlock SAG Revenue

Dividend Yield Range

SAG Dividend Yield Range Unlock SAG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
SAG EPS Forecasts Unlock SAG Revenue
Profile Summary

Science Group plc, formerly Sagentia Group plc, is a United Kingdom-based international science and technology consulting company. The Company provides independent advisory and product development services focused on science and technology initiatives through subsidiary companies branded Sagentia Limited, Oakland Innovation Limited, OTM Consulting Limited and Leatherhead Food Research. The Company operates in two segments: Core Business and Non-Core Business. Its Core Business segment activities include all consultancy fees for services operations, including recharged expenses and product/license revenue, generated directly from these activities. Its Non-Core Business segment activities include rental income from Harston Mill and income from the provision of external information technology (IT) services. Its subsidiaries include Sagentia Technology Advisory Limited, Quadro Design Limited Sagentia Inc., Technology Sciences Group Inc and Technology Sciences (Europe) Limited.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated March 17, 2008
Public Since July 8, 2008
No. of Shareholders: n/a
No. of Employees: 409
Sector Industrials
Industry Professional & Commercial Services
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 41,133,992
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SAG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SAG
Upcoming Events for SAG
Frequently Asked Questions for Science
What is the Science share price?

As of 7:49am, shares in Science are trading at 314p, giving the company a market capitalisation of £129.6m. This share price information is delayed by 15 minutes.

How has the Science share price performed this year?

Shares in Science are currently trading at 314p and the price has moved by 46.51% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Science price has moved by 39.13% over the past year.

What are the analyst and broker recommendations for Science?

Of the analysts with advisory recommendations for Science, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Science is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Science next release its financial results?

Science is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Science dividend yield?

The Science dividend yield is 0.63% based on the trailing twelve month period.

Does Science pay a dividend?

Last year, Science paid a total dividend of 0.02, and it currently has a trailing dividend yield of 0.63%. Looking ahead, Science has not announced an ex-dividend date yet.

When does Science next pay dividends?

Science has yet to annouce their ex-dividend date. The historic dividend yield on Science shares is currently 0.63%.

How do I buy Science shares?

To buy shares in Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Science?

Shares in Science are currently trading at 314p, giving the company a market capitalisation of £129.6m.

Where are Science shares listed? Where are Science shares listed?

Here are the trading details for Science:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: SAG
What kind of share is Science?

Based on an overall assessment of its quality, value and momentum, Science is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Science share price forecast 2021?

Shares in Science are currently priced at 314p. At that level they are trading at 3.97% discount to the analyst consensus target price of 326.98.

Analysts covering Science currently have a consensus Earnings Per Share (EPS) forecast of 0.18132 for the next financial year.

How can I tell whether the Science share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Science. Over the past six months, the relative strength of its shares against the market has been 13.71%. At the current price of 314p, shares in Science are trading at 21.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Science PE Ratio?

The Science PE ratio based on its reported earnings over the past 12 months is 0.347k. The shares are currently trading at 314p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Science?

Science's management team is headed by:

Martyn Ratcliffe - CHM
David Courtley - NID
Michael Lacey-Solymar - NID
Sarah Elizabeth Cole - SEC
Tamara Kahn - DRC
Dan Edwards - MDR
Michael John Withers - MDR
Peter Bertram - NED
Sameet Vohra - CFO
Who are the major shareholders of Science?

Here are the top five shareholders of Science based on the size of their shareholding:

Ratcliffe (Martyn Roy) Individual Investor
Percentage owned: 27.74% (11.4m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 16.82% (6.92m shares)
LF Ruffer Equity & General Fund Mutual Fund
Percentage owned: 11.57% (4.76m shares)
Ruffer LLP Investment Advisor/Hedge Fund
Percentage owned: 10.23% (4.21m shares)
Marlborough Special Situations Retail Mutual Fund
Percentage owned: 9.15% (3.77m shares)
Similar to SAG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.